Literature DB >> 19804438

Anaphylaxis to Patent Blue V. II. A unique IgE-mediated reaction.

S G O Johansson1, A Nopp, H Oman, P Stahl-Skov, A S Hunting, A B Guttormsen.   

Abstract

BACKGROUND: Patent Blue V (PBV) is injected in order to map sentinel nodes during cancer staging procedures. Anaphylactic reactions, allegedly IgE antibody mediated, have been reported. The aim of the study was to explore the immunological mechanism of anaphylaxis to PBV.
METHODS: PBV allergen threshold basophil sensitivity, CD-sens, was performed on cells from nine patients diagnosed as having had adverse reactions to PBV. The mechanisms of the CD-sens were studied by immunological and immuno-chemical methods.
RESULTS: Five of the nine patients had a positive CD-sens to PBV which was completely eliminated by washing the cells in phosphate buffered saline before allergen challenge. However, the positive CD-sens was completely reconstituted by incubating the cells in plasma or serum of that patient or the other PBV-anaphylactic patients for 15 min at room temperature. In some patients the factor mediating CD-sens was completely or partially destroyed by heating at +56 degrees C for 30 min or being exposed to the low pH used for elution from anti-Ig columns. A 1000-fold excess of monoclonal IgE blocked the reconstitution by approximately 50%.
CONCLUSION: Anaphylactic reactions to PBV are mediated by IgE antibodies giving a classical CD-sens reaction. However, the allergenic configuration seems to constitute a structure completely dependent on PBV, as a hapten, linked to a, so far, unknown carrier that seems to be unique for patients having experienced a PBV-induced reaction. Further studies are needed to characterize the postulated carrier.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19804438     DOI: 10.1111/j.1398-9995.2009.02191.x

Source DB:  PubMed          Journal:  Allergy        ISSN: 0105-4538            Impact factor:   13.146


  8 in total

1.  Anaphylaxis to patent blue dye in a 17-year-old boy.

Authors:  Mélanie Leung; Christine McCusker; Moshe Ben-Shoshan
Journal:  BMJ Case Rep       Date:  2019-01-22

Review 2.  Pros and Cons of Clinical Basophil Testing (BAT).

Authors:  Hans Jürgen Hoffmann; Edward F Knol; Martha Ferrer; Lina Mayorga; Vito Sabato; Alexandra F Santos; Bernadette Eberlein; Anna Nopp; Donald MacGlashan
Journal:  Curr Allergy Asthma Rep       Date:  2016-07       Impact factor: 4.806

Review 3.  Anaphylaxis to drug excipients.

Authors:  Wolfgang Pfützner
Journal:  Allergo J Int       Date:  2022-05-31

4.  Anaphylaxis to Patent Blue V: a case series.

Authors:  Ania L Manson; Rohit Juneja; Robert Self; Paul Farquhar-Smith; Fiona Macneill; Suranjith L Seneviratne
Journal:  Asia Pac Allergy       Date:  2012-01-31

Review 5. 

Authors:  Wolfgang Pfützner
Journal:  Allergo J       Date:  2022-07-25

6.  The Pholcodine Case. Cough Medicines, IgE-Sensitization, and Anaphylaxis: A Devious Connection.

Authors:  E Florvaag; S G O Johansson
Journal:  World Allergy Organ J       Date:  2012-07       Impact factor: 4.084

7.  Pholcodine consumption and immunoglobulin E-sensitization in atopics from Australia, Korea, and Japan.

Authors:  Constance H Katelaris; Motohiro Kurosawa; Hee-Bom Moon; Magnus Borres; Erik Florvaag; Stig Gunnar Olof Johansson
Journal:  Asia Pac Allergy       Date:  2014-04-29

Review 8.  [Patent blue V dye anaphylaxis: a case report and literature review].

Authors:  Diogo Costa; Mauro Mendonça; Michael Lopes; Ana Luísa Fernandes; Sara Nunes; Sofia Müller
Journal:  Braz J Anesthesiol       Date:  2020-11-02
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.